Solara Active Pharma Sciences Surges to 52-Week High, Outperforming Sector
Solara Active Pharma Sciences, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs.770 on September 5th, 2024. The stock has outperformed the sector by 0.96% and has shown consecutive gains for the last 4 days. It is currently trading higher than its moving averages and has shown a remarkable growth of 113.69% in the past year.
Solara Active Pharma Sciences, a smallcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high of Rs.770 on September 5th, 2024. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.
The stock has been performing well in the past few days, outperforming the sector by 0.96%. It has also shown consecutive gains for the last 4 days, with a 7.4% increase in returns during this period. Today, the stock opened with a gain of 3.43% and touched an intraday high of Rs.770, showing a positive trend.
Solara Active Pharma Sciences is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance in the market. In the past year, the company's stock has shown a remarkable growth of 113.69%, while the Sensex has only grown by 25.27%.
As a smallcap company in the pharmaceutical industry, Solara Active Pharma Sciences has shown promising growth and potential. However, it is important to note that this article is based on factual information and does not make any recommendations or predictions about the future performance of the company. Investors are advised to do their own research and consult with financial experts before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
